Alerts

Further examples of counterfeit Ozempic-labelled products have been detected and stopped at the Australian border.

Takeda Pharmaceuticals Australia has issued a product alert for Vyvanse capsules due to minor packaging errors. The medication is safe to use as prescribed.

Magnum XXL capsules pose a serious risk to your health and should not be taken.

More prominent warnings are being added to the Product Information and Consumer Medicine Information for all oral and injectable (systemic) fluoroquinolones to strengthen existing warnings about serious side effects.

Extra safety information is being added to all montelukast products to highlight the existing warnings about serious behaviour and mood-related changes

Pharmacists can use a Serious Scarcity Substitution Instrument (SSSI) to dispense Protaphane Penfill human insulin in the place of a Protaphane InnoLet cartridge.

Caruso's Natural Health Pty Ltd is recalling certain batches of WEE LESS, BLOAT EZE and ASHWAGANDHA 7500 due to suspected tampering.

Pharmacists may dispense alternative brands or strengths without a new prescription.

The oral antihistamine promethazine hydrochloride, sold as Phenergan and other generic brands, should not be given to children under 6 years of age.

We have become aware of an increasing number of cases of liver injury reported in scientific literature, by consumers who had taken products containing Garcinia gummi-gutta.

Robust Extreme capsules pose a serious risk to your health and should not be taken.

The TGA has received reports of serious adverse events in infants and children who have been given compounded wind and colic preparations containing Atropa belladonna (belladonna).

Pharmacists can now substitute one Orencia 125 mg product for the other

Sun Herbal Pty Ltd is recalling Clear the Skin Formula a.k.a. Liang Xue Xiao Feng San CM116, a Chinese medicine for skin rash because the label does not display the required warning statement.

Read our safety advisory for Medicines containing Withania somnifera (Withania, Ashwagandha). Be aware of potential gastrointestinal symptoms and very rare cases of liver injury.

There have been reports of the dose counter stopping after the 10th dose and not locking after the 60th dose. If this happens, you should return the product to your place of purchase or contact Boehringer Ingelheim.

Sub Herbal is recalling all batches supplied in Australia of Liu Wei Di Huang Wan (Rehmannia Six Formula) supplements as a precaution. There is potential for the medicine to result in unacceptable amounts of lead.

Kin Fertility Pty Ltd is recalling several batches of The Prenatal capsules due to reported quality problems with the capsules. There is no indication of any safety concerns.

There are new warnings about the risks of heart attack and stroke with taking romosozumab (Evenity). The Product Information (PI) and Consumer Medicine Information (CMI) have been updated to reflect these risks.

Our safety advisory includes information for consumers and health professionals about low levels of nitrosamine impurity in medicines containing sitagliptin.

Find out how we are investigating low levels of the nitrosamine impurity in medicines containing fluoxetine. Read information for consumers and health professionals.

If you've purchased APOHEALTH Paracetamol Pain Relief paracetamol 500 mg film-coated tablets in a bottle, ensure it is kept out of reach of children. This product does not have child-resistant packaging.

The TGA has received reports of liver problems experienced by consumers taking medicines containing turmeric or curcumin.

BioCeuticals is recalling one Batch 220380 (exp 02/2024) of Ultra Potent-C Chewable (60s) (AUST L 208690) following a consumer report of a metal fragment found in one tablet.

The TGA has decided to cancel the registration of pholcodine-containing medicines and is recalling them from pharmacies.